Cypress Capital Management (Wyoming)’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.54K | Hold |
|
|||||
|
2024
Q2 | $1.29K | Hold |
|
|||||
|
2024
Q1 | $4.55K | Sell |
|
|||||
|
2023
Q4 | $3.98K | Hold |
|
|||||
|
2023
Q3 | $8.99K | Hold |
|
|||||
|
2023
Q2 | $15.1K | Hold |
|
|||||
|
2023
Q1 | $26.3K | Hold |
|
|||||
|
2022
Q4 | $57.5K | Sell |
|
|||||
|
2022
Q3 | $70K | Sell |
|
|||||
|
2022
Q2 | $146K | Hold |
|
|||||
|
2022
Q1 | $195K | Sell |
|
|||||
|
2021
Q4 | $203K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $239K | Sell |
|
|||||
|
2021
Q1 | $1.57M | Sell |
|
|||||
|
2020
Q4 | $1.23M | Sell |
|
|||||
|
2020
Q3 | $2.51M | Sell |
|
|||||
|
2020
Q2 | $3.08M | Sell |
|
|||||
|
2020
Q1 | $2.38M | Sell |
|
|||||
|
2019
Q4 | $2.97M | Buy |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q2 | – | Hold |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.43M | Buy |
|